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ABSTRACT
RNA polymerase (pol) III transcription decreases
whenprimaryculturesofratneonatalcardiomyocytes
are exposed to low oxygen tension. Previous studies
infibroblastshaveshownthatthepolIII-specifictran-
scription factor IIIB (TFIIIB) is bound and regulated
by the proto-oncogene product c-Myc, the mitogen-
activated protein kinase ERK and the retinoblastoma
tumour suppressor protein, RB. The principal func-
tion of TFIIIB is to recruit pol III to its cognate gene
template, an activity that is known to be inhibited by
RB and stimulated by ERK. We demonstrate by chro-
matin immunoprecipitation (ChIP) that c-Myc also
stimulates pol III recruitment by TFIIIB. However,
hypoxic conditions cause TFIIIB dissociation from
c-Myc and ERK, at the same time as increasing its
interactionwithRB.Consistentwiththis,ChIPassays
indicatethattheoccupancyoftRNAgenesbypolIIIis
significantly reduced, whereas promoter binding by
TFIIIBisundiminished.Thedatasuggestthathypoxia
can inhibit pol III transcription by altering the interac-
tions between TFIIIB and its regulators and thus
compromising its ability to recruit the polymerase.
These effects are independent of cell cycle changes.
INTRODUCTION
In most eukaryotic organisms, cellular oxygen concentrations
are precisely regulated in order to maintain an adequate sub-
strate supply for oxidative phosphorylation and other essential
metabolic reactions. A decrease in oxygen tension (hypoxia) is
a common feature of several pathological situations, such as
tumourigenesis, ischemia and venous diseases. Mammalian
cells can adapt to oxygen deprivation by inducing protective
mechanisms, which include expression of speciﬁc gene prod-
ucts and cell cycle arrest (1–6). Another well-characterized
consequence of hypoxic stress is a pronounced decrease in
the rate of oxygen consumption and of energy turnover (7–9).
This correlates with a substantial and rapid drop in the rate of
protein biosynthesis, involving changes at the level of both
translation and transcription (8,10–14).
RNA polymerase (pol) III plays a key role in protein syn-
thesis by catalysing the production of small, untranslated RNA
molecules, such as tRNA and 5S rRNA, which are involved
in fundamental metabolic processes (15). Transcription factor
IIIB (TFIIIB) and TFIIIC are two transcription factor com-
plexes that are required for transcription of most pol III tem-
plates (15–17). In the majority of cases, TFIIIC is responsible
for promoter recognition by binding directly to DNA. TFIIIC
then recruits TFIIIB by protein–protein interactions and
directs pol III to the transcription start site (15–17). The syn-
thesis of tRNA and 5S rRNA by pol III is cell cycle regulated
in higher organisms (18). In addition, overexpression of pol III
products is a general feature of transformed cells (19–21).
These observations can be explained by the fact that TFIIIB
isstronglyregulatedby thetumoursuppressorproteinsRBand
p53, as well as the proto-oncogene product c-Myc and the
extracellular signal-regulated kinase ERK (22–26). Both RB
and p53 repress pol III transcription by binding to TFIIIB and
sequestering it in an inactive complex (22,26–30). In contrast,
c-Myc and ERK can bind to and activate TFIIIB, causing a
potent induction of pol III transcription (24,25).
Since hypoxia causes a down-regulation of RNA and pro-
tein synthesis (7), we investigated its effect on pol III tran-
scription. Primary cultures of rat neonatal cardiomyocytes
were utilized, since they have been widely used as a model
to study the effect of hypoxia. When such cells were incubated
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doi:10.1093/nar/gkj402in 1% oxygen, a decrease in protein synthesis was found to
accompany an inhibition of pol III transcription. Under these
conditions, hypoxia did not raise levels of p53, a known regu-
lator of pol III. Indeed, a much lower oxygen concentration
was found previously to be required to stabilize p53 levels in
cardiomyocytes (31). The amount of c-Myc is also not altered
in the low oxygen environment. However, co-immunopreci-
pitation revealed that the ability of c-Myc to bind TFIIIB is
compromised. Furthermore, both the activity of ERK and its
interaction with TFIIIB decrease during hypoxia. In contrast,
binding of TFIIIB to its repressor RB increases when
cardiomyocytes are exposed to low oxygen, an effect that
correlates with dephosphorylation of RB. Chromatin immuno-
precipitation (ChIP) shows that the association of pol III with
tRNA genes is decreased in hypoxic cardiomyocytes, although
TFIIIB and TFIIIIC remain bound. The data suggest that
hypoxia inhibits pol III transcription under these conditions
by reducing the recruitment of polymerase to promoters, most
likely as a consequence of altered interactions between TFIIIB
and its positive and negative regulators.
MATERIALS AND METHODS
Cell culture
Myocytes were dissociated from the ventricles of neonatal
Sprague–Dawley rat hearts by a previously described adapta-
tion of the method of Iwaki et al. (32,33). To deplete the
myocytes of ﬁbroblasts, the cells were pre-plated in
DMEM/Medium-199 (4:1, v/v) supplemented with 10% (v/v)
horse serum (HS), 5% (v/v) heat-inactivated foetal calf serum
(FCS), penicillin (100 U/ml) and streptomycin (100 mg/ml).
The (non-adherent) myocytes were then plated into 6-well
culture dishes precoated with 1% (w/v) gelatin at a density
of 1.4 · 10
3 cells/mm
2. After 18 h, the medium was replaced
with the same medium containing 4% HS and no FCS. Experi-
ments were carried out in the same medium but containing
10% FCS. For hypoxia, cultures were incubated in a hypoxic
incubator (Wolf Laboratories, UK) with a gas mixture con-
taining 1% O2 and 5% CO2, balanced with nitrogen. Prior
to placing the cells in the incubator, the culture medium
was replaced with fresh medium that had been equilibrated
overnight with the same gas mixture. Cells under normoxic
conditions were treated in the same way, but using a gas mix
of 20% O2,5 %C O 2.
HIF-1a tetracycline (TetOn)-inducible SAOS2 cells were
cultured using the method of Bardos et al. (34). Wild-type
and c-myc-null ﬁbroblasts were cultured as described previ-
ously (35). Preparation and use of c-MycER-transduced
ﬁbroblasts has been described (36).
Western immunoblotting analysis
Cells were washed twice in ice-cold phosphate-buffered saline
(PBS) then scraped in RIPA buffer [50 mM HEPES pH 7.5,
150 mM NaCl, 5 mM EDTA, 10 mM NaF, 10 mM sodium
phosphate, 1% (v/v) Triton X-100, 0.5% (w/v) sodium
deoxycholate, 0.1% (w/v) SDS, 0.1 mM phenylmethylsulfonyl
ﬂuoride (PMSF), 10 mg/ml soybean trypsin inhibitor and
10 mg/ml benzamidine]. Buffers used for hypoxic samples
were de-oxygenated before use. Samples were centrifuged at
10000 g for 15 min at 4 C. Western immunoblot analysis was
performed as described by White et al. (37).
Antibodies used were N-15 against TFIIIC63, D-2 against
ERK, 9E10 against c-Myc, C-15 against RB and 58C9
against TBP (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA). The p53, phospho-RB (Ser-795) and phospho-ERK
(Thr-202/Tyr-204) antibodies were from New England
Biolabs. Peptide antisera 1900 against RPC155 subunit of
pol III, Ab2 against TFIIIC220, 4286 against TFIIIC110
and 1898 against TFIIIC90 subunits of TFIIIC, and 2663
against Bdp1, and 128 against Brf1 subunits of TFIIIB have
been characterized previously (29,38–41). Antiserum against
BN51 was generously provided by Michael Ittman (42).
Protein synthesis measurement
Rates of protein synthesis were assayed in cardiomyocytes
by measuring the incorporation of [
35S]methionine/cysteine
into acid-insoluble material as described previously (43).
Approximately 10 mCi of radioisotope (>1000 Ci/mmol)
was used per well of the culture dish.
In vitro transcription assay
Whole-cell extracts were prepared for transcription assays
using the freeze-thaw procedure as previously described
(37). Pol III transcription assays were carried out as in
White et al. (44), except that transcriptions were for 60 min
at 30 C.
Immunoprecipitations
Cells were washed twice in ice-cold PBS and scraped into
IP buffer [50 mM HEPES pH 7.5, 5 mM EDTA, 10 mM
NaF, 150 mM NaCl, 25% glycerol, 0.5% Triton X-100,
0.5 mM PMSF, 0.5 mg/ml leupeptin, 0.7 mg/ml pepstatin,
0.5 mg/ml aprotinin, 40 mg/ml bestatin, 1 mM sodium vanadate
and 50 mM b-glycerophosphate]. After 15 min on ice, the
extracts were passed three times through a 26G needle and
insoluble material was removed by centrifugation at 14000 g
for 15 min prior to immunoprecipitation. Extracts (500 mg)
were incubated on an orbital shaker with 30 ml of protein A–
Sepharose beads carrying an equivalent amount of prebound
IgG. Samples were then pelleted, supernatants removed and
the beads washed three times with 300 ml Tris-buffered saline.
The bound material was analysed by western blotting.
Northern blotting
Total cellular RNA was extracted using TRI reagent (Sigma),
accordingtothe manufacturer’sinstructions. Agarosegel elec-
trophoresis, northern transfer and hybridization were carried
out as described previously (22). The B2 gene probe was a
240 bp EcoRI–PstI fragment from pTB14 (44). The acidic
ribosomal phosphoprotein P0 (ARPP P0) probe was a 1 kb
EcoRI–HindIII fragment from mouse cDNA (45). The 18S
rRNA probe was a 80 bp fragment from a highly conserved
region of the gene (Ambion, Inc.).
RT–PCR analysis
RNA was extracted as above. Reverse transcription reactions
were performed for 1 h at 42 C using 3 mg of RNA, 200 ng of
Random Hexamers (Promega) and 400 U of Superscript II
Reverse Transcriptase (Life Technologies) in a total volume
Nucleic Acids Research, 2006, Vol. 34, No. 1 287of 40 mlo f1 · First Strand Buffer (Life Technologies) con-
taining 10 mM DTT and 0.5 mM concentration of each dNTP.
PCRs were carried out using a Techgene thermal controller
(Wolf Laboratories, UK). cDNA (2 ml) was ampliﬁed with
20 pmol of either tRNA
Leu primers (50-GTCAGGATGGCC-
GAGTGGTCTAAGGCGCC-30 and 50-CCACGCCTCCATA-




GGATGTCC-30) to give an 84 bp product, 5S rRNA primers
(50-GGCCATACCACCCTGAACGC-30 and 50-CAGCACC-
CGGTATTCCCAGG-30) to give a 107 bp product or ARPP
P0 primers (50-GCACTGGAAGTCCAACTACTTC-30 and
50-TGAGGTCCTCCTTGGTGAACAC-30) to give a 265 bp
product. Ampliﬁcation reactions contained 0.5 U of Taq DNA
polymerase (Promega) in a total volume of 1· Taq DNA
polymerase buffer (Promega) containing 1.5 mM MgCl2
and 0.2 mM concentration of each dNTP and 1.8 mCi of
[a-
32P]dCTP (10 mCi/ml, 3000 Ci/mmol). PCR was per-
formed under the following cycling parameters: (i) ARPP
P0, 95 C for 2 min, 18 cycles of 95 C for 1 min, 58 C for
30 s and 72 C for 1 min; 72 C for 3 min; (ii) tRNA
Leu,9 5  C
for 3 min, 25 cycles of 95 C for 30 s, 68 C for 30 s and 72 C
for 30 s; 72 C for 5 min; (iii) tRNA
Tyr,9 5  C for 3 min,
25 cycles of 95 C for 1 min, 62 C for 30 s and 72 C for
30 s; 72 C for 5 min; (iv) 5S rRNA, 95 C for 3 min, 18 cycles
of 95 C for 30 s, 58 C for 30 s and 72 C for 1 min; 72 C
for 5 min. Reaction products were resolved on a 7% polyacry-
lamide gel containing 7M urea and 0.5· TBE. Radioacti-
vity was visualized by autoradiography and quantiﬁed by
phosphorimaging.
Polymerase assay
Random polymerase assays were performed as before (46).
Each mixture contained 5 mg of poly(dA–dT) template and
10 mg of whole-cell extract. Pol III activity was calculated by
subtracting the polymerization obtained in the presence of
200 mg/ml a-amanitin (due to pol I) from that obtained in
the presence of 1 mg/ml a-amanitin (due to pol III plus pol I).
Chromatin immunoprecipitation assay
ChIP was performed as in Gomez-Roman et al. (25). Immuno-
precipited DNA was quantiﬁed by PCR performed using
previously described primers and ampliﬁcation procedures
(25). Antibodies used were C-18 against TFIIB (Santa Cruz
Biotechnologies), 128 against Brf1, 2663 against Bdp1,
MTBP-6 against TBP, 4286 against TFIIIC110, Ab2 against
TFIIIC220, 114 against pol III subunit RPC53 and 1900
against pol III subunit RPC155 (29,38–41). Serial dilutions
of chromatin were used to establish that PCRs were within a
linear range.
RESULTS
Pol III transcription decreases when cardiomyocytes
are exposed to low oxygen
Exposure of many cell types to hypoxic conditions has been
shown to decrease protein synthesis, although the mechanisms
responsible have not been fully elucidated (10–14). This is
also observed when cardiomyoctes are incubated in 1%
oxygen (Figure 1A). Protein synthesis starts to decrease
between 4 and 8 h following exposure of these cells to
hypoxia. No signiﬁcant difference in the level of apoptosis
or necrosis was detected between cells incubated in the nor-
moxic or hypoxic environment (data not shown). The effect of
hypoxia on pol III transcription can clearly be seen by moni-
toring pol III transcripts derived from the middle repetitive
gene family B2, which have a short half-life and so provide a
reliable indication of transcriptional output. The abundance of
B2 RNA was reduced by 40% when cardiomyocytes were
incubated for 8 h in 1% O2 (Figure 1B and C). In contrast,
levels of the pol I-transcribed 18S rRNA did not diminish
under the same conditions (Figure 1B). This effect was con-
ﬁrmed using RT–PCR, in which levels of pol III transcripts
B2, tRNA
Leu and tRNA
Tyr were measured. Primers that
hybridize speciﬁcally to the intron sequences of short-lived
precursors of the tRNAs were used. Because introns are pro-
cessed from primary transcripts and then degraded very
rapidly, their levels in a cell reﬂect the rate of ongoing tran-
scription (47). Levels of B2 and the primary transcripts
tRNA
Tyr and tRNA
Leu were signiﬁcantly reduced after 8 h
incubation in hypoxia (Figure 1D). In contrast, levels of
mRNA encoding ARPP P0 did not diminish under the same
conditions.
The levels of pol III, TFIIIB and TFIIIC remain
relatively constant in hypoxia-treated cardiomyocytes
To investigate whether the reduction in pol III activity under
hypoxic conditions is due to lower levels of pol III transcrip-
tion factors, western blots were carried out with extracts from
cells grown in 1% oxygen for various times. Up to 16 h in
hypoxia produced little or no change in levels of the Bdp1,
TBP and Brf1 subunits of TFIIIB, or the 220, 110, 90 or 63
kDa subunits of TFIIIC (Figure 2A). Levels of the RPC155
and RPC53 subunits of pol III also remain unchanged in
response to hypoxia, as does that of actin (Figure 2A).
Although antibodies are not available to monitor every subunit
of TFIIIC and pol III in rat cells, the available data provide no
evidence for a change in the abundance of pol III-speciﬁc
transcription factors or pol III itself when cardiomyocytes
become hypoxic.
We assayed the ability of pol III to catalyse randomly ini-
tiated RNA synthesis independently of transcription factors,
using a poly(dA–dT) template. No signiﬁcant difference in the
level of random polymerization by pol III was observed
between extracts prepared from cells incubated in normoxic
or hypoxic conditions (data not shown). Nevertheless, pol III
transcriptional activity was clearly diminished in these
extracts. Thus, extracts prepared from cardiomyocytes treated
for 16 h in hypoxia were found to transcribe a pol III template
signiﬁcantly less actively than extracts prepared from
cells grown in normoxic conditions, reﬂecting the situation
in vivo (Figure 2B).
Pol III recruitment to tRNA promoters is reduced
under hypoxic conditions
Although hypoxia caused little or no variation in the abun-
dance of speciﬁc pol III transcription factors nor in the cat-
alytic activity of the pol III enzyme, we investigated whether
288 Nucleic Acids Research, 2006, Vol. 34, No. 1occupancy at pol III promoters was affected. ChIP experi-
ments were carried out on cardiomyocytes incubated for
16 h under hypoxic or normoxic conditions. Formaldehyde
cross-linked soluble chromatin was prepared from these
cells and, following normalization for DNA content, these
were immunoprecipitated (IP) with antibodies against TFIIIB
(Bdp1, Brf1 and TBP) as well as TFIIIC (220 and 110 sub-
units) and pol III (subunit RPC53). PCR analysis of precipi-
tated DNA showed that TFIIIC, Bdp1 and TBP occupancy of
tRNA
Leu genes are essentially unaffected when cardiomy-
ocytes are incubated in 1% oxygen (Figure 3). However,
pol III occupancy at tRNA genes is decreased by 60%
Figure 1. Incubation of cardiomyocytes in low oxygen reduces pol III
activity. (A) Cardiomyocytes were incubated in 20% (N) or 1% O2 (H)
for 2, 4, 8, 16 or 24 h and [
35S]methionine added to the medium 30 min prior
to harvesting. Samples were processed to measure incorporation of label into
trichloroacetic acid-precipitable material.Data areexpressedas d.p.m./mg pro-
tein ± SD, where n ¼ 3. (B) Northern blot analysis of total RNA (20 mg)
extracted from cardiomyocytes cultured in 20% (N) or 1% O2 (H) for 4, 8
or 16 h. The upper panel shows the blot probed with a B2 gene, and the lower
panel shows the same blot that has been stripped and reprobed with the rDNA
gene. (C) Results from (B) were quantified and normalized against the rRNA
signal.ThegraphshowsthemeanandSDsfromthreeindependentexperiments;
values obtained for the 4 h normoxic sample were set to 100 and other values
calculated as a percentage of this. (D) cDNAs were generated by reverse
transcription of RNA from cells treated as in (B), as indicated. These cDNAs
were PCR amplified using primers specific for the indicated template.
Figure 2. Down-regulationofpolIIIactivityinhypoxiaisnotduetoadecrease
in the abundance of TFIIIB, TFIIIC or pol III subunits. (A) Cardiomyocytes
culturedin20%(N)or1%O2(H)for4,8or16hwereresolvedonanSDS–7.8%
polyacrylamide gel and then analysed by western immunoblotting with anti-
bodiesspecifictothe63,90,110and220kDasubunitsofTFIIIC,theTBP,Brf1
and Bdp1 subunits of TFIIIB, and the 53 and 155 kDa subunits of pol III, as
indicated. (B) Whole-cell extract was prepared from cardiomyocytes cultured
for16hin1%(H1andH2)or20%(N1andN2)O2.Template(500ng)VA1was
used for in vitro transcription assay using 15 mg of these extracts.
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merase recruitment when hypoxic stress is applied.In contrast,
Brf1 crosslinking is elevated under hypoxic conditions. Since
Brf1 is known to bind directly to pol III, this apparent anomaly
may be explained if the accessibility of Brf1 to antibody
increases when pol III occupancy falls. The observed drop
in pol III interaction with its templates offers an explanation
for the decrease in transcription of these genes under low
oxygen.
Hypoxia alters the interactions of TFIIIB with its
regulators RB, c-Myc and ERK
Several regulatory factors have been shown to inﬂuence the
function of the pol III machinery (19,21,48). For example,
TFIIIB is a speciﬁc target for repression by RB and p53
(22,26–30,49). Conversely, both c-Myc and ERK can bind
TFIIIB and activate pol III transcription (24,25). Western
blot analysis detected little or no change in the levels of RB,
p53,c-MycorERKwhencardiomyocyteswere exposedforup
to 16 h in 1% oxygen (Figure 4A). Since pol III transcription is
sensitive to the phosphorylation status of RB, this was also
Figure 3. Culture of cardiomyocytes in hypoxia compromises the promoter
occupancy by pol III. (A) ChIP assay showing levels of Bdp1, Brf1, TBP,
TFIIIC (TFIIIC 110 and 220 subunits), pol III (RPC53 subunit) and TFIIB
associated with the tRNA
Leu gene in cardiomyocytes cultured for 16 h in
normoxic (N) or hypoxic (H) conditions. (B) Quantification of ChIP assays.
PCR products from three independent ChIP experiments were quantified for
tRNAgenes;afternormalizationtoinput,themeanandSDsareshownwiththe
normoxicvalueineachcasesetto100andthehypoxicvalueexpressedrelative
to this (*significantly different from control, P < 0.05).
Figure 4. The phosphorylation status of RB and ERK decreases when
cardiomyocytes are cultured in 1% O2.( A) Cardiomyocytes cultured in 20%
(N)or1%O2(H)for4,8or16hwereresolvedonanSDS–7.8%polyacrylamide
gel and then analysed by western immunoblotting with antibodies specific to
RBphosphorylatedatSer-795(p-RB),RB,ERKphosphorylatedatThr-202and
Tyr-204 (p-ERK), ERK, c-Myc, p53 and actin, as indicated. (B) Cell extracts
(500 mg) were prepared from rat neonatal cardiomyocytes cultured for 16 h in
normoxic(lanes1and4)orhypoxic(lanes2,3and5)conditions.ThesewereIP
with anti-c-Myc (lanes 1 and 2, upper panel), anti-ERK (lanes 1 and 2, middle
panel), anti-RB(lanes1and 2,lowerpanel) oranti-4E-BP1(lane 3,all panels).
Precipitates were resolved by SDS–PAGE and then analysed by western
blotting with anti-Brf1 antibody. 10% input samples are shown in lanes
4 and 5.
290 Nucleic Acids Research, 2006, Vol. 34, No. 1measured in these cells; it is the underphosphorylated form of
RBthatbinds andrepressesTFIIIB(50).Westernblottingwith
a phospho-speciﬁc antibody revealed a decrease in RB phos-
phorylation at Ser795 within8ho fincubation in 1% oxygen
(Figure 4A). This correlates with the down-regulation of pol
III transcription observed in these cells. ERK activation in
response to mitogens stimulates pol III transcription via phos-
phorylation of TFIIIB (24). Since ERK must be phosphory-
lated before it can activate TFIIIB, the phosphorylation status
of the kinase was measured. Although hypoxia can cause a
rapid, acute activation of ERK in some cell types (51,52),
incubating cardiomyocytes for 8 h in low oxygen resulted
in a decrease in phospho-ERK and phosphorylation was
almost abolished by 16 h (Figure 4A).
ERK, c-Myc and RB all regulate pol III transcription by
interacting with TFIIIB (24,25,27–29). We therefore tested
whether hypoxia alters the association of these proteins
using co-immunoprecipitation. Extracts were prepared from
cardiomyocytes exposed for 16 h in normoxic or hypoxic
conditions and c-Myc, RB or ERK immunoprecipitates
were probed by western using a speciﬁc antibody against
the Brf1 subunit of TFIIIB. Both ERK and c-Myc were
found to associate with Brf1 in cells grown at normal oxygen
concentrations, but this interaction is substantially
reduced in low oxygen (Figure 4B, upper two panels). In
contrast, the amount of RB that associates with Brf1 is greatly
increased in hypoxia (Figure 4B, lower panel). These co-
precipitations reﬂect speciﬁc interactions, since Brf1 is not
co-immunoprecipitated in either a normoxic or hypoxic envi-
ronment with a control antiserum against the translational
regulator 4E-BP1 (Figure 4B, lane 3, and data not shown).
Whereas all previous studies have used immortalized cell
lines, these data conﬁrm that TFIIIB also binds to c-Myc,
RB and ERK in primary cells. They also reveal that the con-
stellation of regulators associated with TFIIIB is dynamic, and
changes dramatically in response to hypoxia.
HIF-1a can associate with c-Myc and regulate
pol III transcription
The altered interaction of TFIIIB with ERK and RB correlates
with the observed change in phosphorylation status of these
proteins in 1% oxygen (Figure 4A). In contrast, phosphoryla-
tion has not been shown to inﬂuence the binding of c-Myc to
TFIIIB. However, recent work has suggested that c-Myc func-
tion is compromised under low oxygen conditions through the
action of HIF-1a, which displaces c-Myc from some of its
targets (53,54). These studies reported a weak and probably
indirect association of HIF-1a with c-Myc in hypoxic human
cell lines, so we investigated if this could also be detected in
primary rat cardiomyocytes. To this end, we immunoprecipi-
tated c-Myc from cardiomyocytes incubated for 16 h in nor-
moxiaorhypoxia,andtestedby western blottingforbindingof
HIF-1a. Treatment with 1% oxygen resulted in induction of
HIF-1a (Figure5A, lanes 4and 5) and its appearance in anti-c-
Myc immunocomplexes (Figure 5A, lane 2). This is consistent
with a model in which HIF-1a interacts with c-Myc in hypoxic
cardiomyocytesand interferes with itsability toactivate polIII
transcription. To begin to test this hypothesis, we used a cell
system in which HIF-1a can be induced with doxycycline
under normoxic conditions (34); these cells are negative for
both RB and p53, thus excluding two known mediators of
polIII regulation.Since ithas been shown that HIF-1a induces
p21
cip1 gene expression by blocking c-Myc function (53), we
used this gene as a positive control. Indeed, addition of doxy-
cycline to these cells did enhance p21
cip1 mRNA levels, as
reportedpreviously(Figure 5B). Furthermore,thiswas accom-
panied by a speciﬁc decrease in tRNA and 5S rRNA, suggest-
ing that expression of HIF-1a can inhibit synthesis of pol III
transcripts, possibly through an effect on c-Myc. As above, the
tRNA primers used in this experiment are speciﬁc for the
short-lived primary transcripts and therefore provide a
measure of ongoing transcription.
Pol III recruitment is stimulated by c-Myc
The ChIP assays above showed a speciﬁc reduction in tem-
plate occupancy by pol III in 1% oxygen. Although ERK and
RB have both been demonstrated to inﬂuence pol III recruit-
ment by TFIIIB, this has yet to be shown for c-Myc. To test
this, we used ChIP to compare pol III occupancy in matched
wild-type and c-Myc-knockout Rat1 cells. This revealed that
Figure 5. HIF-1a can bind c-Myc and regulate pol III transcription. (A) Cell
extracts (500 mg) were prepared from rat neonatal cardiomyocytes cultured for
16hinnormoxic(lanes1and4)orhypoxic(lanes2,3and5)conditions.These
were IP with anti-c-Myc (lanes 1 and 2) or anti-4E-BP1 (lane 3) antibodies.
Precipitates were resolved by SDS–PAGE and then analysed by western
blotting with anti-HIF-1a antibody. Input samples (10%) are shown in lanes
4 and 5. (B) Saos-2 HIF-1a TetOn-inducible cells were treated with or without
doxycycline (DOX; 2 mg/ml) for 18 h. cDNAs were generated by reverse




Arg, 5S rRNA and ARPP P0, as indicated.
Nucleic Acids Research, 2006, Vol. 34, No. 1 291the interaction of pol III with tRNA genes is markedly dimin-
ished in the cells from which c-Myc has been selectively
deleted (Figure 6A). The association is speciﬁc, as the pol
II transcription factor TFIIB which was used a control was
not detected at the tRNA genes and the pol III antibody did not
immunoprecipitate DNA from within the coding region of the
ARPP P0 gene. As an independent test, we also used a murine
ﬁbroblast cell line carrying a c-MycER construct, which can
be rapidly induced by the addition of hydroxy-tamoxifen
(OHT) for 4 h. These cells were starved of serum, to silence
expression of endogenous c-Myc, and then harvested for
ChIP analysis either with or without OHT treatment. Pol III
occupancy of tRNA genes increased substantially and specif-
ically within 4 h of c-MycER induction (Figure 6B).
We conclude that c-Myc can promote the recruitment of
pol III to its targets, consistent with its established ability
to stimulate pol III transcription. The diminished interaction
between c-Myc and TFIIIB is therefore likely to contribute to
the observed reduction in polymerase occupancy under low
oxygen conditions.
DISCUSSION
In primary cultures of rat cardiomyocytes, low oxygen con-
ditionsreducethe transcriptional outputofpolIII,aswell asits
association with target genes. Although not all subunits were
examined, we detected no change in the level or catalytic
activity of pol III. We also found little or no change in the
expression of TFIIIB and TFIIIC or in their occupancy of
tRNA genes. However, the interaction of TFIIIB with regu-
latory factors was altered quite markedly, with increased bind-
ing toitsinhibitorRBand decreasedbindingto itsactivators c-
Myc and ERK. TFIIIB isresponsible forrecruiting polIII toits
templates (16,17). Previous studies have shown that ERK
stimulates the interaction between TFIIIB and pol III (24),
whereas RB has the opposite effect (29). Here we have demon-
strated that c-Myc can also stimulate the ability of TFIIIB to
recruit pol III to its target genes. The dissociation of TFIIIB
from c-Myc and ERK, as well as its binding to RB, can there-
fore explain the reduced occupancy of tRNA genes by pol III
in low oxygen and hence the diminished rates of transcription.
Ourdata suggesta modelin which the dissociationofc-Myc
fromTFIIIBmightbemediatedbyHIF-1a.Ithasbeenreported
that the stabilization of HIF-1a under hypoxic conditions
antagonizes c-Myc function and displaces it from several pro-
moters, including that of the p21
cip1 gene (53,54).
We conﬁrmed the effect of HIF-1a on p21
cip1 expression
using cells in which doxycycline was added to speciﬁcally
induce HIF-1a activity (34); such a system allows one to dis-
tinguish the effects of HIF-1a from other responses to hypoxic
conditions. Induction of HIF-1a also resulted in a signiﬁcant
decreaseinpolIIItranscriptlevels.Thus,inactivationofc-Myc
byHIF-1a might contribute to the decrease in polIII transcrip-
tionatlowoxygentension,although muchfurther workwillbe
required to test this rigorously. Although we have yet to estab-
lish the mechanism(s) responsible for dissociating c-Myc from
TFIIIB, the binding of ERK and RB to TFIIIB is known to be
regulated by phosphorylation (24,50). Interaction of ERK with
TFIIIBrequiresthattheformerisphosphorylatedandactivated
by MEK (24); western blotting showed a reversal of ERK
activation in low oxygen, thereby explaining its release from
TFIIIB. Conversely, it is the hypophosphorylated form of RB
that binds and regulates TFIIIB (50) and it is this form that
predominates under hypoxic conditions. Oxygen deprivation
therefore leads to an overall exchange of TFIIIB partners from
activators to a potent repressor.
We had anticipated that p53 might contribute to the regu-
lation of pol III transcription under these conditions, as
hypoxia is known to be one of the stresses that can stabilize
and activate p53 (55). However, studies of the p53 response to
low oxygen generally use chemical mimetics of anoxia or
oxygen concentrations of 0.1% or less (31,55,56). We
found that the milder conditions of 1% oxygen used here
were insufﬁcient to provoke a p53 response in cardiomy-
ocytes, even though other molecular changes were clearly
observed. This is consistent with a previous study, using a
colon carcinoma cell line, which found that p53 induction
begins at 0.5% oxygen, but is not apparent in 1% oxygen,
even after 48 h incubation (56).
Assays of protein–protein interactions, in vitro and in vivo,
indicated that RB and ERK inﬂuence the binding of TFIIIB to
both TFIIIC and pol III; ERK stimulates these steps, whereas
Figure 6. Pol III recruitment to tRNA genes is stimulated by c-Myc. (A) ChIP




 / ( / )cells.(B)ChIP
assay showing levels of pol III (RPC155 subunit) and TFIIB associated with
tRNA
Leu and ARPP P0 genes in MycER-transduced murine fibroblasts treated
with 4-OHT for 0 h (uninduced) or 4 h (induced). Quantitative PCR was
performed with equivalent DNA input amounts determined by PCR on 1:10
and 1:100 diluted input chromatin (upper panel).
292 Nucleic Acids Research, 2006, Vol. 34, No. 1RB blocks them (24,29). Since TFIIIB is recruited to tRNA
genes by TFIIIC, we had predicted that its promoter occu-
pancy would respond to RB and ERK. This is supported by
ChIP analyses which conﬁrmed that RB-bound TFIIIB is
not associated with tRNA genes in cycling HeLa cells (57).
We were therefore surprised to ﬁnd that release of ERK and
increased binding of RB does not dissociate TFIIIB from
promoters in hypoxic cardiomyocytes,although we doobserve
the predicted change in pol III occupancy. Although differ-
ences in cell type might be invoked, we suggest that a key
difference between this and previous studies is that the car-
diomyocytes used here have withdrawn permanently from the
cell cycle. In proliferating cells, we would expect pol III tran-
scription complexes to be displaced from promoters by DNA
replication (58); their stability may therefore be enhanced
considerably in non-replicating, post-mitotic cardiomyocytes.
Perhaps in the absence of replication, mammalian TFIIIB can
remain promoter-bound even if its contacts with TFIIIC have
been weakened; this is certainly the situation in Saccha-
romyces, where TFIIIC is required to recruit TFIIIB, but
not for its subsequent retention (59). In contrast, the recruit-
ment of pol III by TFIIIB must occur for every round of
transcription and may accordingly be much more immediately
responsive to changes in ERK and/or RB activity. This may
explain why it is only pol III occupancy that decreases in
hypoxic cells; even a stable preinitiation complex must recruit
polymerase to allow multiple rounds of transcription. A failure
of pol III recruitment is clearly sufﬁcient to give the observed
decrease in transcriptional output. However, the complexes
remain poised on tRNA gene promoters, ready to resume
activity if oxygen levels rise.
The ability to reduce macromolecular synthesis is an impor-
tantcomponentofthe protectiveresponsetohypoxia.Wehave
demonstrated that oxygen deprivation causes a clear reduction
in gene expression by pol III. This is likely to provide a sub-
stantial saving in energy consumption, since pol III is respon-
sible for around 10% of all nuclear transcription. When
aerobic metabolism is curtailed, such energy conservation
may make a signiﬁcant contribution to a cell’s chances of
survival.
ACKNOWLEDGEMENTS
We thank Margaret Ashcroft for helpful discussions and for
accesstotheHIF-1aTetOn-inducible cells,CarlaGrandorifor
c-MycER-transduced fibroblasts, Sonia Rocha for RNA sam-
ples, Arnie Berk for antisera against TFIIIC220 and Michael
Ittmann for antisera against RPC53. This work has been
supported by project grants from The Wellcome Trust
(068710 and 062625) and Chest, Heart and Stroke Scotland
(02/A62).Fundingtopaythe OpenAccess publication charges
for this article was provided by University of Glasgow.
Conflict of interest statement. None declared.
REFERENCES
1. Gardner,L.B., Li,Q., Park,M.S., Flanagan,W.M., Semenza,G.L. and
Dang,C.V.(2001)HypoxiainhibitsG1/Stransitionthroughregulationof
p27 expression. J. Biol. Chem., 276, 7919–7926.
2. Goda,N., Ryan,H.E., Khadivi,B., McNulty,W., Rickert,R.C. and
Johnson,R.S. (2003) Hypoxia-inducible factor 1a is essential for cell
cycle arrest during hypoxia. Mol. Cell. Biol., 23, 359–369.
3. Harris,A.L. (2002) Hypoxia—a key regulatory factor in tumour growth.
Nature Rev. Cancer, 2, 38–47.
4. Kumar,G.K. and Klein,J.B. (2004) Analysis of expression and
posttranslational modification of proteins during hypoxia. J. Appl.
Physiol., 96, 1178–1186.
5. Denko,N.C., Fontana,L.A., Hudson,K.M., Sutphin,P.D.,
Raychaudhuri,S., Altman,R. and Giaccia,A.J. (2003) Investigating
hypoxictumourphysiologythroughgeneexpressionpatterns.Oncogene,
22, 5907–5914.
6. Roy,S., Khanna,S., Bickerstaff,A.A., Subramanian,S.V., Atalay,M.,
Bierl,M., Pendyala,S., Levy,D., Sharma,N., Venojarvi,M. et al. (2003)
Oxygen sensing by primary cardiac fibroblasts: A key role of p21(Waf1/
Cip1/Sdi1). Circ. Res., 92, 264–271.
7. Casey,T.M., Pakay,J.L., Guppy,M. and Arthur,P.G. (2002) Hypoxia
causes downregulation of protein and RNA synthesis in noncontracting
mammalian cardiomyocytes. Circ. Res., 90, 777–783.
8. Koumenis,C., Naczki,C., Koritzinsky,M., Rastani,S., Diehl,A.,
Sonenberg,N., Koromilas,A. and Wouters,B.G. (2002)
Regulation of protein synthesis by hypoxia via activation of the
endoplasmic reticulum kinase PERK and phosphorylation of
the translation initiation factor eIF2 alpha. Mol. Cell. Biol., 22,
7405–7416.
9. Arthur,P.G., Giles,J.J. and Wakeford,C.M. (2000) Protein synthesis
duringoxygenconformanceandseverehypoxiainthemousemusclecell
line C2C12. Biochim. Biophys. Acta, 1475, 83–89.
10. Hochachka,P.W., Buck,L.T., Doll,C.J. and Land,S.C. (1996) Unifying
theory of hypoxia tolerance: molecular/metabolic defence and rescue
mechanisms for surviving oxygen lack. Proc. Natl Acad. Sci. USA, 93,
9493–9498.
11. Pettersen,E.O., Juul,N.O. and Ronning,O.W. (1986) Regulation of
protein-metabolism of human-cells during and after acute-hypoxia.
Cancer Res., 46, 4346–4351.
12. Clark,L., Fillenwarth,M.J., Shen,W.H. and Boyle,D.W. (2003) Effect of
hypoxiaontranslationinitiationfactorsintheC2C12skeletalmusclecell
line over time. FASEB J., 17, A1285.
13. Tinton,S.A. and Buc-Calderon,P.M. (1999) Hypoxia increases the
associationof4E-bindingprotein1withtheinitiationfactor4Einisolated
rat hepatocytes. FEBS Lett., 446, 55–59.
14. Kraggerud,S.M., Sandvik,J.A. and Pettersen,E.O. (1995) Regulation of
protein-synthesisinhuman-cellsexposedtoextremehypoxia.Anticancer
Res., 15, 683–686.
15. White,R.J. (2002) RNA Polymerase III Transcription 3rd edn. Landes
Bioscience, Austin.
16. Geiduschek,E.P. and Kassavetis,G.A. (2001) The RNA polymerase III
transcription apparatus. J. Mol. Biol., 310, 1–26.
17. Schramm,L. and Hernandez,N. (2002) Recruitment of RNA polymerase
III to its target promoters. Genes Dev., 16, 2593–2620.
18. White,R.J., Gottlieb,T.M., Downes,C.S. and Jackson,S.P. (1995) Cell
cycle regulation of RNA polymerase III transcription. Mol. Cell. Biol.,
15, 6653–6662.
19. White,R.J. (2004) RNA polymerase III transcription—a battleground for
tumour suppressors and oncogenes. Eur. J. Cancer, 40, 21–27.
20. Felton-Edkins,Z.A., Kenneth,N.S., Brown,T.R.P., Daly,N.L., Gomez-
Roman,N., Grandori,C., Eisenman,R.N. and White,R.J. (2003) Direct
regulation of RNA polymerase III transcription by RB, p53 and c-Myc.
Cell Cycle, 2, 181–184.
21. White,R.J. (2004) RNA polymerase III transcription and cancer.
Oncogene, 23, 3208–3216.
22. Cairns,C.A. and White,R.J. (1998) p53 is a general repressor of RNA
polymerase III transcription. EMBO J., 17, 3112–3123.
23. White,R.J., Trouche,D., Martin,K., Jackson,S.P. and Kouzarides,T.
(1996) Repression of RNA polymerase III transcription by the
retinoblastoma protein. Nature, 382, 88–90.
24. Felton-Edkins,Z.A., Fairley,J.A., Graham,E.L., Johnston,I.M.,
White,R.J. and Scott,P.H. (2003) The mitogen-activated protein (MAP)
kinase ERK induces tRNA synthesis by phosphorylating TFIIIB. EMBO
J., 22, 2422–2432.
25. Gomez-Roman,N., Grandori,C., Eisenman,R.N. and White,R.J. (2003)
Direct activationof RNA polymerase III transcriptionby c-Myc.Nature,
421, 290–294.
Nucleic Acids Research, 2006, Vol. 34, No. 1 29326. Chesnokov,I., Chu,W.M., Botchan,M.R. and Schmid,C.W. (1996) p53
inhibits RNA polymerase III-directed transcription in a promoter-
dependent manner. Mol. Cell. Biol., 16, 7084–7088.
27. Larminie,C.G.C., Cairns,C.A., Mital,R., Martin,K., Kouzarides,T.,
Jackson,S.P. and White,R.J. (1997) Mechanistic analysis of RNA
polymerase III regulation by the retinoblastoma protein. EMBO J.,
16, 2061–2071.
28. Chu,W.-M., Wang,Z., Roeder,R.G. and Schmid,C.W. (1997) RNA
polymerase III trancription repressed by Rb through its interactions with
TFIIIB and TFIIIC2. J. Biol. Chem., 272, 14755–14761.
29. Sutcliffe,J.E., Brown,T.R.P., Allison,S.J., Scott,P.H. and White,R.J.
(2000) Retinoblastoma protein disrupts interactions required for RNA
polymerase III transcription. Mol. Cell. Biol., 20, 9192–9202.
30. Crighton,D., Woiwode,A., Zhang,C., Mandavia,N., Morton,J.P.,
Warnock,L.J., Milner,J., White,R.J. and Johnson,D.L. (2003)
p53 represses RNA polymerase III transcription by targetting TBP
andinhibitingpromoteroccupancybyTFIIIB.EMBOJ.,22,2810–2820.
31. Long,X.L., Boluyt,M.O., Hipolito,M.D., Lundberg,M.S., Zheng,J.S.,
O’Neill,L., Cirielli,C., Lakatta,E.G. and Crow,M.T. (1997) p53 and the
hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes.
J. Clin. Invest., 99, 2635–2643.
32. Iwaki,K., Sukhatme,V.P., Shubeita,H.E. and Chien,K.R. (1990) Alpha-
adrenergic and beta-adrenergic stimulation induces distinct patterns of
immediateearlygene-expressioninneonatalratmyocardial-cells.fos/jun
expression is associated with sarcomere assembly—egr-1 induction is
primarily an alpha-1-mediated response. J. Biol. Chem., 265,
13809–1381.
33. Bogoyevitch,M.A., Ketterman,A.J. and Sugden,P.H. (1995) Cellular
stresses differentially activate c-jun n-terminal protein-kinases and
extracellular signal-regulated protein-kinases in cultured ventricular
myocytes. J. Biol. Chem., 270, 29710–29717.
34. Bardos,J.I.,Chau,N.-M.andAshcroft,M.(2004)Growthfactor-mediated
induction of HDM2 positively regulates hypoxia-inducible factor 1a
expression. Mol. Cell. Biol., 24, 2905–2914.
35. Mateyak,M.K., Obaya,A.J., Adachi,S. and Sedivy,J.M. (1997)
Phenotypes of c-myc-deficient rat fibroblasts isolated by targeted
homologous recombination. Cell Growth Differ., 8, 1039–1048.
36. Grandori,C., Gomez-Roman,N., Felton-Edkins,Z.A., Ngouenet,C.,
Galloway,D.A., Eisenman,R.N. and White,R.J. (2005) c-Myc binds to
human ribosomal DNA and stimulates transcription of rRNA genes by
RNA polymerase I. Nature Cell Biol., 7, 311–318.
37. White,R.J., Gottlieb,T.M., Downes,C.S. and Jackson,S.P.(1995) Mitotic
regulation of a TATA-binding-protein-containing complex. Mol. Cell.
Biol., 15, 1983–1992.
38. Alzuherri,H. and White,R.J. (1998) Regulation of a TATA-binding
protein-associated factor during cellular differentiation. J. Biol. Chem.,
273, 17166–17171.
39. Shen,Y., Igo,M., Yalamanchili,P., Berk,A.J. and Dasgupta,A. (1996)
DNAbindingdomainandsubunitinteractionsoftranscriptionfactorIIIC
revealed by dissection with poliovirus 3C protease. Mol. Cell. Biol., 16,
4163–4171.
40. Felton-Edkins,Z.A. and White,R.J. (2002) Multiple mechanisms
contribute to the activation of RNA polymerase III transcription in cells
transformed by papovaviruses. J. Biol. Chem., 277, 48182–48191.
41. Fairley,J.A., Scott,P.H. and White,R.J. (2003) TFIIIB is phosphorylated,
disrupted and selectively released from tRNA promoters during mitosis
in vivo. EMBO J., 22, 5841–5850.
42. Ittman,M., Ali,J., Greco,A. and Basilico,C. (1993) The gene
complementingatemperature-sensitivecellcyclemutantofBHKcellsis
thehumanhomologue oftheyeastRPC53gene,whichencodesasubunit
of RNA polymerase C (III). Cell Growth Differ., 4, 503–511.
43. Welsh,G.I. and Proud,C.G. (1992) Regulation of protein-synthesis in
swiss 3t3 fibroblasts. Rapid activation of the guanine-nucleotide-
exchange factor by insulin and growth-factors. Biochem. J., 284, 19–23.
44. White,R.J., Stott,D. and Rigby,P.W.J. (1989) Regulation of RNA
polymeraseIIItranscriptioninresponsetoF9embryonalcarcinomastem
cell differentiation. Cell, 59, 1081–1092.
45. Hurford,R.K., Cobrinik,D., Lee,M.-H. and Dyson,N. (1997) pRB and
p107/p130 are required for the regulated expression of different sets of
E2F responsive genes. Genes Dev., 11, 1447–1463.
46. Roeder,R.G.(1974)Multipleformsofnucleicacid-dependentribonucleic
acid polymerase in Xenopus laevis. J. Biol. Chem., 249, 241–248.
47. Winter,A.G., Sourvinos,G., Allison,S.J., Tosh,K., Scott,P.H.,
Spandidos,D.A.andWhite,R.J.(2000)RNApolymeraseIIItranscription
factor TFIIIC2 is overexpressed in ovarian tumours. Proc. Natl Acad.
Sci. USA, 97, 12619–12624.
48. White,R.J.(2005)RNApolymerasesIandIII,growthcontrolandcancer.
Nature Rev. Mol. Cell. Biol., 6, 69–78.
49. Hirsch,H.A., Gu,L. and Henry,R.W. (2000) The retinoblastoma tumour
suppressorproteintargetsdistinctgeneraltranscriptionfactorstoregulate
RNA polymerase III gene expression. Mol. Cell. Biol., 20, 9182–9191.
50. Scott,P.H., Cairns,C.A., Sutcliffe,J.E., Alzuherri,H., McLees,A.,
Winter,A.G. and White,R.J. (2001) Regulation of RNA polymerase III
transcription during cell cycle entry. J. Biol. Chem., 276, 1005–1014.
51. Minet,E., Michel,A.G., Roland,I., Mottet,D., Raes,M., Remacle,J. and
Michiels,C. (2000) ERK activation upon hypoxia: involvement in HIF-1
activation. FEBS Lett., 468, 53–58.
52. Jin,N.J.,Hatton,N.,Swartz,D.R.,Xia,X.L.,Harrington,M.A.,Larsen,S.H.
and Rhoads,R.E. (2000) Hypoxia activates Jun-N-terminal kinase,
extracellularsignal-regulatedproteinkinase,andp38kinaseinpulmonary
arteries. Am. J. Respir. Cell Mol. Biol., 23, 593–601.
53. Koshiji,M., Kageyama,Y., Pete,E.A., Horikawa,I., Barrett,J.C. and
Huang,L.E. (2004) HIF-1a induces cell cycle arrest by functionally
counteracting Myc. EMBO J., 23, 1949–1956.
54. Koshiji,M., To,K.K.-W., Hammer,S., Kumamoto,K., Harris,A.L.,
Modrich,P.andHuang,L.E.(2005)HIF-1ainducesgeneticinstabilityby
transcriptionally downregulaing MutSa expression. Mol. Cell, 17,
793–803.
55. Graeber,T.G., Peterson,J.F., Tsai,M., Monica,K., Fornace,A.J. and
Giaccia,A.J. (1994) Hypoxia induces accumulation of p53 protein, but
activation of a G1-phase checkpoint by low-oxygen conditions is
independent of p53 status. Mol. Cell. Biol., 14, 6264–6277.
56. Achison,M.andHupp,T.R.(2003)Hypoxiaattenuatesthep53responseto
cellular damage. Oncogene, 22, 3431–3440.
57. Hirsch,H.A., Jawdekar,G.W., Lee,K.-A., Gu,L. and Henry,R.W. (2004)
Distinct mechanisms for repression of RNA polymerase III transcription
by the retinoblastoma tumour suppressor protein. Mol. Cell. Biol., 24,
5989–5999.
58. Wolffe,A.P. and Brown,D.D. (1986) DNA-replication in vitro erases a
Xenopus 5S RNA gene transcription complex. Cell, 47, 217–227.
59. Kassavetis,G.A., Braun,B.R., Nguyen,L.H. and Geiduschek,E.P. (1990)
S.cerevisiae TFIIIB is the transcription initiation factor proper of
RNA polymerase III, while TFIIIA and TFIIIC are assembly factors.
Cell, 60, 235–245.
294 Nucleic Acids Research, 2006, Vol. 34, No. 1